30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

2Q13 Revenue: Mathys

(1H13 sales only)

CHF 65.7MM (~US $69.3MM), +7%

  • Subsidiaries in Australia, China, Japan and New Zealand grew +41% over last year
  • Launched bone-conserving hip stem
  • International multi-center study of Ligamys implant for cruciate ligament repair continues to yield promising results